Neuropharmacology

Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective
pp. 2223-2230(8)
Authors: Bruno V.; Ksiazek I.; Battaglia G.; Lukic S.; Leonhardt T.; Sauer D.; Gasparini F.; Kuhn R.; Nicoletti F.; Flor P.J.

Activation of group I metabotropic glutamate receptors induces long-term depression at sensory synapses in superficial spinal dorsal horn
pp. 2231-2243(13)
Authors: Chen J.; Heinke B.; Sandkuhler J.

Imidazoline-induced neuroprotective effects result from blockade of NMDA receptor channels in neuronal cultures
pp. 2244-2254(11)
Authors: Milhaud D.; Fagni L.; Bockaert J.; Lafon-Cazal M.

Role of NMDA receptor functional domains in excitatory cell death
pp. 2255-2266(12)
Authors: Rameau G.A.; Akaneya Y.; Chiu L.-Y.; Ziff E.B.

Tyrosine phosphorylation-dependent inhibition of hippocampal synaptic plasticity
pp. 2267-2277(11)
Authors: Coussens C.M.; Williams J.M.; Ireland D.R.; Abraham W.C.

Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence
pp. 2278-2287(10)
Authors: Popik P.; Wrobel M.; Nowak G.

Postsynaptic hyperpolarization increases the strength of AMPA-mediated synaptic transmission at large synapses between mossy fibers and CA3 pyramidal cells
pp. 2288-2301(14)
Authors: Berretta N.; Rossokhin A.V.; Kasyanov A.M.; Sokolov M.V.; Cherubini E.; Voronin L.L.

Inhibition of the 5-HT_1A receptor-mediated inwardly rectifying K⁺ current by dextromethorphan in rat dorsal raphe neurones
pp. 2302-2308(7)
Authors: Ishibashi H.; Kuwano K.; Takahama K.

Chronic clomipramine alters presynaptic 5-HT_1B and postsynaptic 5-HT_1A receptor sensitivity in rat hypothalamus and hippocampus, respectively
pp. 2309-2317(9)
Authors: Newman M.E.; Gur E.; Dremencov E.; Garcia F.; Lerer B.; Van de Kar L.D.

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT_2C/2B receptor antagonists: neurochemical and behavioural studies
pp. 2318-2328(11)
Authors: Hutson P.H.; Barton C.L.; Jay M.; Blurton P.; Burkamp F.; Clarkson R.; Bristow L.J.

Characterization of lipopolysaccharide-induced emesis in conscious piglets: effects of cervical vagotomy, cyclooxygenase inhibitors and a 5-HT₃ receptor antagonist
pp. 2329-2335(7)
Authors: Girod V.; Bouvier M.; Grelot L.

Bradycardic responses to microinjection of N-methyl-d-aspartate into the nucleus tractus solitarius are inhibited by local activation of 5-HT₃ receptors
pp. 2336-2345(10)
Authors: Bonagamba L.G.H.; Sevoz-Couche C.; N'Diaye A.; Uygun-Louvet K.; Callera J.-C.; Machado B.H.; Hamon M.; Laguzzi R.

5-HT₃ receptor function and potentiation by alcohols in frontal cortex neurons from transgenic mice overexpressing the receptor
pp. 2346-2351(6)
Authors: Sung K.-W.; Engel S.R.; Allan A.M.; Lovinger D.M.

Sibutramine, a serotonin uptake inhibitor, increases dopamine concentrations in rat striatal and hypothalamic extracellular fluid
pp. 2352-2359(8)
Authors: Balcioglu A.; Wurtman R.J.

Regulation of GIRK channel deactivation by G_q and G_i/o pathways
pp. 2360-2373(14)
Authors: Mark M.D.; Ruppersberg J.P.; Herlitze S.

GTP differentially affects antagonist radioligand binding to adenosine A₁ and A_2A receptors in human brain
pp. 2374-2380(7)
Authors: Kull B.; Svenningsson P.; Hall H.; Fredholm B.B.

Adenosine 5'-tetraphosphate (Ap₄), a new agonist on rat midbrain synaptic terminal P2 receptors
pp. 2381-2390(10)
Authors: Gomez-Villafuertes R.; Gualix J.; Miras-Portugal M.T.; Pintor J.

Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice
pp. 2391-2398(8)
Authors: Mamiya T.; Noda Y.; Noda A.; Hiramatsu M.; Karasawa K.; Kameyama T.; Furukawa S.; Yamada K.; Nabeshima T.

GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors
pp. 2399-2407(9)
Author: Dalby N.O.

Multi-neuronal recordings reveal a differential effect of thapsigargin on bicuculline- or gabazine-induced epileptiform excitability in rat hippocampal neuronal networks
pp. 2408-2417(10)
Authors: Sokal D.M.; Mason R.; Parker T.L.

Anticonvulsant effect and neurotransmitter modulation of focal and systemic 2-chloroadenosine against the development of pilocarpine-induced seizures
pp. 2418-2432(15)
Authors: Khan G.M.; Smolders I.; Ebinger G.; Michotte Y.

Hippocampal extracellular amino acids and EEG spectral analysis in a genetic rat model of absence epilepsy
pp. 2433-2441(9)
Authors: Richards D.A.; Morrone L.A.; Bowery N.G.

The effects of nandrolone decanoate on cocaine-induced kindling in male rats
pp. 2442-2447(6)
Authors: Long S.F.; Wilson M.C.; Davis W.M.

Steroidogenesis in rat brain induced by short- and long-term administration of carbamazepine
pp. 2448-2456(9)
Authors: Serra M.; Littera M.; Pisu M.G.; Muggironi M.; Purdy R.H.; Biggio G.

Use of the radioligand [¹²⁵I]-SB-217644 in the characterisation and solubilisation of the novel binding site for the anticonvulsant SB-204269 in rat brain membranes and cell lines
pp. 2457-2463(7)
Authors: Herdon H.J.; Godfrey F.M.; Chan W.N.

Strain-dependent neurochemical and neuroendocrine effects of desipramine, but not fluoxetine or imipramine, in Spontaneously Hypertensive and Wistar-Kyoto rats
pp. 2464-2477(14)
Authors: Durand M.; Aguerre S.; Fernandez F.; Edno L.; Combourieu I.; Mormede P.; Chaouloff F.

Behavioral and neurochemical alterations following repeated phencyclidine administration in rats with neonatal ventral hippocampal lesions
pp. 2478-2491(14)
Authors: Hori T.; Subramaniam S.; Srivastava L.K.; Quirion R.

Opposite modulation of histaminergic neurons by nociceptin and morphine
pp. 2492-2498(7)
Authors: Eriksson K.S.; Stevens D.R.; Haas H.L.

Reversal of pertussis toxin-induced thermal allodynia by muscarinic cholinergic agonists in mice
pp. 2499-2504(6)
Authors: Womer D.E.; Shannon H.E.

RANTES: a new prostaglandin dependent endogenous pyrogen in the rat
pp. 2505-2513(9)
Authors: Tavares E.; Minano F.J.